Free Trial

Athira Pharma (ATHA) Insider Trading & Ownership

Athira Pharma logo
$9.86 +0.44 (+4.67%)
As of 05/7/2026

Athira Pharma (NASDAQ:ATHA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
19.80%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$50.91K
Get ATHA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Athira Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATHA Insider Buying and Selling by Quarter

Athira Pharma Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/2/2026
Mark James Litton
CEO
Sell2,586$6.88$17,791.68  
1/2/2026
Mark Worthington
General Counsel
Sell876$6.88$6,026.88  
1/2/2026
Martin Javier San
Insider
Sell1,644$6.88$11,310.72  
1/2/2026
Robert Renninger
CFO
Sell297$6.88$2,043.36  
7/1/2025
Mark James Litton
CEO
Sell2,512$2.90$7,284.80  
7/1/2025
Mark Worthington
General Counsel
Sell852$2.90$2,470.80  
7/1/2025
Martin Javier San
Insider
Sell1,084$2.90$3,143.60  
7/1/2025
Robert Renninger
SVP
Sell289$2.90$838.10  
(Data available from 1/1/2013 forward)

ATHA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Athira Pharma includes Andrew Gengos, Kelly A Romano, Mark James Litton, Mark Worthington, Martin Javier San, Perceptive Advisors Llc, Rachel Lenington, and Robert Renninger. Learn more on insiders at ATHA.

19.80% of Athira Pharma stock is owned by insiders. Learn more on ATHA's insider holdings.

The following insider purchased ATHA shares in the last 24 months: Kelly A Romano ($100,208.00).

Insiders have purchased a total of 4,240 ATHA shares in the last 24 months for a total of $100,208.00 bought.

The following insiders have sold ATHA shares in the last 24 months: Andrew Gengos ($723.90), Mark James Litton ($41,999.58), Mark Worthington ($13,263.28), Martin Javier San ($20,513.52), Rachel Lenington ($1,436.40), and Robert Renninger ($4,494.26).

Insiders have sold a total of 15,753 Athira Pharma shares in the last 24 months for a total of $82,430.94 sold.



This page (NASDAQ:ATHA) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners